-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T35sNaDpOlf1n7Mtmd8u5dbJQj7DQexyCt5Pkia4F8ZH6WWFWItz7gehO33EGl81 Jk2J5yVkZtyI7+n2AoUZVw== 0001209191-05-000837.txt : 20050104 0001209191-05-000837.hdr.sgml : 20050104 20050104155112 ACCESSION NUMBER: 0001209191-05-000837 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041231 FILED AS OF DATE: 20050104 DATE AS OF CHANGE: 20050104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THIER SAMUEL O MD CENTRAL INDEX KEY: 0001144773 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03305 FILM NUMBER: 05507206 BUSINESS ADDRESS: BUSINESS PHONE: 9786586000 MAIL ADDRESS: STREET 1: C/O CHARLES RIVER LABORATORIES STREET 2: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERCK & CO INC CENTRAL INDEX KEY: 0000064978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221109110 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DR STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 9084234044 MAIL ADDRESS: STREET 1: ONE MERCK DR STREET 2: PO BOX 100 WS3AB-05 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2004-12-31 0 0000064978 MERCK & CO INC (MRK) 0001144773 THIER SAMUEL O MD MASSACHUSETTS GENERAL HOSPITAL 55 FRUIT ST., BULFINCH 370 BOSTON MA 02114-2606 1 0 0 0 Phantom Stock 2004-12-31 4 A 0 838.519 32.14 A Common Stock 838.519 10444.185 D 1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. Debra A. Bollwage as Attorney-in-Fact for Samuel O. Thier 2005-01-04 -----END PRIVACY-ENHANCED MESSAGE-----